Authors

• Alwin D. R. Huitema (ORCID: https://orcid.org/0000-0003-1939-4639)
• Frans L. Opdam (ORCID: https://orcid.org/0000-0002-9489-6535)
• Rob ter Heine (ORCID: https://orcid.org/0000-0003-2185-8201)
• Ingrid A Boere (ORCID: https://orcid.org/0000-0002-4857-6346)
• Marjolijn J. L. Ligtenberg (ORCID: https://orcid.org/0000-0003-1290-1474)
• Nielka P. van Erp (ORCID: https://orcid.org/0000-0003-1553-178X)
• Wietske Kievit (ORCID: https://orcid.org/0000-0002-3984-1769)
• Gabe S. Sonke (ORCID: https://orcid.org/0000-0001-8088-9628)
• Niels A.D. Guchelaar (ORCID: https://orcid.org/0000-0001-8080-9093)
• Joanneke K. Overbeek (ORCID: https://orcid.org/0000-0002-8802-4124)
• Petronella B. Ottevanger (ORCID: https://orcid.org/0000-0001-8209-487X)
• Haiko J. Bloemendal (ORCID: https://orcid.org/0000-0002-8902-4337)
• Stijn L.W. Koolen (ORCID: https://orcid.org/0000-0002-0973-7530)
• Ron H.J. Mathijssen (ORCID: https://orcid.org/0000-0001-5667-5697)
• Ma Ida Mohmaed Ali (ORCID: https://orcid.org/0000-0002-6853-6763)
• Muriëlle Sark
• Carolien Hovenier (ORCID: https://orcid.org/0009-0005-3473-5421)

Institutions

• Radboud University Nijmegen (NL)
• Utrecht University (NL)
• Erasmus MC (NL)
• Radboud University Medical Center (NL)
• The Netherlands Cancer Institute (NL)
• University Medical Center Utrecht (NL)
• Borstkankervereniging Nederland (NL)
• Oncode Institute (NL)
• Florence (Netherlands) (NL)
• Princess Máxima Center (NL)
• Erasmus MC Cancer Institute (NL)

Publication Details

Journal

Contemporary Clinical Trials Communications

Published

2025-04-01

DOI

https://doi.org/10.1016/j.conctc.2025.101477

Citations

2

Primary Topic

PARP inhibition in cancer therapy

Type

article

Field-Weighted Citation Impact

2.09

Funders

• Amgen
• ZonMw
• Nederlandse Federatie van Universitair Medische Centra